Survival First: Three Chinese Biotechs Downsize R&D Amid Funding Downturn

 
• By Dexter Jie Yan
  
R&D cuts
Some Chinese biotechs start to save for a rainy day to prevent cashflow • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia